CSIMarket


Elanco Animal Health Inc  (ELAN)
Other Ticker:  
 


 

Elanco Animal Health Inc

ELAN's Financial Statements and Analysis



Elanco Animal Health Inc increased forth quarter of 2023 net loss per share of $-0.28 compare to net loss per share of $-0.11 recorded in the same quarter a year ago and improved compare to net loss per share of $-2.22 realized in previous quarter.


forth quarter of 2023
Earnings Per Share Revenues
$ -0.28 $  1,035 Mill
$-0.17     $+54M     +5.5 %



Elanco Animal Health Inc's Revenue rose by 5.5 % in forth quarter of 2023 (Dec 31 2023) year on year, to $1,035 million and declined by -3.09 % sequentially.


Elanco Animal Health Inc is

More on ELAN's Income Statement



Elanco Animal Health Inc's in theforth quarter of 2023 recorded net loss of $-141.000 million, an increase from net loss of $-55.000 million in IV. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-1,096.000 million realized in previous quarter.

More on ELAN's Growth

Elanco Animal Health Inc Inventories
Inventories grew by 12.81 % to $1,735 million from IV. Quarter a year ago, sequentially inventories rose by 2.66 %. In Dec 31 2023 company's net cash and cash equivalents decreased by $-17 million, capital expenditures fell by -7977.22%, to $-140 millions compare to same quarter a year ago

More on ELAN's Cash flow Statement


Elanco Animal Health Inc does not pay out common stock dividend.

In trailing twelve-month period Elanco Animal Health Inc earned $ 0.55 cash per share, on a free-cash flow basis .

Book value grew by 1.51 % sequentially to $12.64 per share.
Tangible Book value fell to $ -6.83 per share from $ -6.58.

Company repurchased 0.30 million shares or 0.06 % in Dec 31 2023.


More on ELAN's Dividends

 Market Capitalization (Millions) 7,824
 Shares Outstanding (Millions) 492
 Total Debt (Millions $) 5,774
 Revenue (TTM) (Millions $) 4,417
 Net Income (TTM) (Millions $) -1,231
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) -178
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,550




Elanco Animal Health Inc does not pay out common stock dividend.

In trailing twelve-month period Elanco Animal Health Inc had $ 0.55 cash flow per share, on a free-cash flow basis .

Book value grew by 1.51 % sequentially to $12.64 per share.
Tangible Book value fell to $ -6.83 per share from $ -6.58.

Company repurchased 0.30 million shares or 0.06 % in Dec 31 2023.


More on ELAN's Balance Sheets

 Market Capitalization (Millions) 7,824
 Shares Outstanding (Millions) 492
 Total Debt (Millions $) 5,774
 Revenue (TTM) (Millions $) 4,417
 Net Income (TTM) (Millions $) -1,231
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) -178
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,550
   


  News about Elanco Animal Health Inc Earnings

Elanco Animal Health Inc Faces Deficit Despite Revenue Growth in Fiscal Fourth Quarter 2023



The recent financial results of Elanco Animal Health Inc for the fiscal fourth quarter of 2023 have caught the attention of investors and industry experts alike. The company's performance, unlike its peers in the Major Pharmaceutical Preparations industry, saw a substantial improvement in revenue growth and earnings per share. Furthermore, amidst concerns about methane emissions from livestock, Elanco Animal Health has partnered with Athian, a leading technology company, to develop innovative solutions that address this environmental challenge. This article interprets the financial results and explores the potential implications for Elanco Animal Health going forward.
Revenue Growth and Earning...

Elanco Animal Health Inc Sees Increased Losses and Revenue Decline in Second Quarter of 2023

Elanco Animal Health Inc Faces Challenges as Fiscal Performance Declines
Elanco Animal Health Inc, a prominent player in the animal health industry, recently reported its fiscal performance for the period between April and June 2023. The results painted a challenging picture for the company, indicating a significant decrease in revenue and a larger-than-expected net shortfall.
Comparing this quarter's performance to the same period last year, Elanco reported a shortfall per share of $-0.20, a notable increase from $-0.04. Additionally, earnings per share fell from $0.21 in the previous reporting season. The revenue also took a hit, declining by -10.195% to $1.06 billion from $1.18 billion in the corr...

Elanco Animal Health Inc Surpasses Expectations with Strong Profit Margin Growth in Fiscal Q1 of 20232.

Investors in the stock market will be pleased to hear that Elanco Animal Health Inc has delivered impressive income growth on slow revenue advance in the financial period closing Mar 31 2023. With EPS grown rapidly by 110% at $0.21 per share and revenue rising slightly by 2.612% to $1.26 billion from the corresponding reporting season a year ago, Elanco Animal Health Inc has shown solid improvement in their financial standing.
Comparing the current reporting season to the previous one, we see an impressive turnaround as EPS turned positive from $-0.11 per share and revenue improved by 28.135% from $981.00 million. This significant growth is a testament to the hard work and dedication of the company and i...


Date modified: 2024-02-26T20:46:41+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com